Capecitabine is a standard component of first-line chemotherapy, and ramucirumab has demonstrated clinical efficacy in advanced OGA. 9 - 11 Randomization across five treatment arms commenced in April ...

Ongoing Results From a Dose Expansion Cohort of CYT-0851 in Combination With Capecitabine in Advanced Platinum-Resistant Ovarian Cancer Show Promising Clinical Activity and Generally Well ...

The frequency and type of follow-up assessment are dependent on the prescribed medication, cycle number, and clinical necessity. Monitoring assessments for capecitabine were performed weekly during ...